CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops a novel vaccine technology that significantly shortens the manufacturing time for vaccines, enabling quicker responses to health emergencies. The technology utilizes self-assembly of specific proteins around nucleic acids to create vaccines, aiming to improve public health outcomes during outbreak…
Common to current manufacturing technologies for vaccines is the long lead-time before they were made available or novel vaccines could be made available to the public.
Current methods are very time consuming and frequently encounter problems with scale-up, in particular if sudden demands have to be met.
However, the ability to start vaccination campaigns fast – and earlier than currently possible – is particularly important in view of seasonal influenza, influenza pandemics or sudden outbreaks…
GEZA AD LTD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
